
    
      OBJECTIVES: I. Compare survival and quality of life in asymptomatic patients with advanced
      colorectal cancer randomized to immediate fluorouracil/leucovorin (5-FU/CF) vs. 5-FU/CF
      delayed until onset of symptoms.

      OUTLINE: Randomized, unblinded study. Arm I: Single-Agent Chemotherapy with Drug Modulation.
      Fluorouracil, 5-FU, NSC-19893; with Leucovorin calcium, CF, NSC-3590. Arm II: Observation
      followed by Single-Agent Chemotherapy with Drug Modulation. Clinical observation until
      symptomatic; followed by 5-FU; with CF.

      PROJECTED ACCRUAL: 144 patients will be entered over 4 years.
    
  